Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
J Cosmet Dermatol ; 22(2): 370-377, 2023 Feb.
Article in English | MEDLINE | ID: covidwho-2192841

ABSTRACT

BACKGROUND: COVID-19 pandemic has caused mask-related skin problems on health-care professions, yet very few studies have investigated the prevalence in oriental general population. OBJECTIVE: To investigate the prevalence of mask-related adverse skin reactions in Orientals, to explore psychological influence, to identify risk factors for mask-related acne exacerbation. METHODS: We performed a survey through social media. Participant demographics, skin condition before and after COVID-19, and the influence of adverse skin on social-psychological conditions were collected. We compared characteristics between individuals with or without acne exacerbation, and we performed a logistic regression to identify risk factors. RESULTS: Six hundred and six participants (62.3%) responded the survey and 23.3% complained their facial acnes become exacerbated since COVID-19. The social-psychological impact of acnes is more prevalent in women. Risk factors for mask-related acne exacerbation were occupation as health-care workers (OR = 1.861, p = 0.027), prolonged wearing of N95 masks (OR = 3.167, p = 0.001), and touching of acnes (OR = 2.65, p = 0.002). Sex, pre-existed acnes, and prolonged wearing time per day are also associated with acne exacerbation. CONCLUSIONS: Mask-related adverse skin reactions are common in Orientals, and could lead to negative social-psychological effects.


Subject(s)
Acne Vulgaris , COVID-19 , Humans , Female , Prevalence , Pandemics , COVID-19/epidemiology , Acne Vulgaris/epidemiology , Risk Factors
2.
Eur Rev Med Pharmacol Sci ; 26(19): 7305-7312, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-2081435

ABSTRACT

OBJECTIVE: Acne vulgaris is a common skin disease worldwide. Throughout the COVID-19 pandemic, many patients with acne complained of worsening symptoms. This investigation was designed to survey the impact of COVID-19 regulations on acne and guide patients with acne on symptom management during the pandemic. MATERIALS AND METHODS: From April 7th to April 21st, 2020, an anonymous, self-completed, web-based questionnaire was distributed to patients previously diagnosed with acne (via the Chinese internet medical software). Information collected included patients' mask-wearing routines and behavioral factors including dietary habits, sleep habits, facial hygiene, and make-up use habits. RESULTS: 508 qualified questionnaire responses were collected. During the COVID-19 outbreak in China, there was an overall worsening of patients' acne symptoms (152, 29.9%). Behaviors including intake of sweets (34.9% vs. 16.0%, p<0.01), dairy consumption (32.9% vs. 23.3%, p<0.05), greasy (19.1% vs. 11.2%, p<0.05) and spicy food intake (30.3% vs. 14.3%, p<0.01) and mask-wearing frequency (>28 hours per week) (25.0% vs. 15.3%, p<0.05) presented a statistically significant difference between the acne aggravated and non-aggravated groups. Longtime mask-wearing (>28 hours per week), rather than the mask type, was significantly associated with acne symptom deterioration during the COVID-19 outbreak (odds ratio [OR]: 2.164; 95% confidence interval [CI]: 1.232-3.801). CONCLUSIONS: Besides the well-known risk factors, such as sweets intake, dairy consumption, and greasy and spicy food intake, wearing masks appears to trigger or aggravate acne during the COVID-19 pandemic. Limiting overall mask-wearing time may help to manage acne.


Subject(s)
Acne Vulgaris , COVID-19 , Humans , COVID-19/epidemiology , Pandemics , Cross-Sectional Studies , Acne Vulgaris/epidemiology , China/epidemiology , Internet , Masks
3.
PLoS One ; 17(6): e0269922, 2022.
Article in English | MEDLINE | ID: covidwho-2021810

ABSTRACT

Following the worldwide COVID-19 pandemic, individuals have begun to take preventive measures to avoid exposure. Among the precautionary measures, facemask was mostly emphasized. This study aimed to determine the prevalence of dermatological symptoms linked with face mask usage and explore other associated factors. This cross-sectional survey was conducted throughout all eight divisions of Bangladesh. 1297 people were approached using a fixed-step procedure on a random route sample where 803 fulfilled the inclusion criteria. The overall prevalence of dermatological manifestation in this study was 40.85%. The common dermatological manifestations due to facemasks use were acne (26%), allergy symptoms (24%), traumatic symptoms (24%), and other symptoms (26%). Two important frequently reported risk factors were previous history of skin diseases and obesity. Females were more likely to have acne (CI: 1.199, 3.098; p = .007) and allergy issues (CI: 1.042, 2.359; p = .031). N95 and KN95 masks were more likely to produce allergic symptoms, while surgical mask users were more likely to develop acne. Acne was prevalent more than twice (CI: 1.42, 4.26; p = 0.001) in persons with a COVID-19 infection history. Further exploration is required to find out the reason. Surgical mask users reported more complaints than other types of masks, and prolonged use caused more skin symptoms. Modifications in the pattern of facemask usage and planning for work recesses might also be advised to provide for a pause from uninterrupted facemask use.


Subject(s)
Acne Vulgaris , COVID-19 , Hypersensitivity , Skin Diseases , Acne Vulgaris/epidemiology , Acne Vulgaris/etiology , Bangladesh/epidemiology , COVID-19/epidemiology , Cross-Sectional Studies , Female , Humans , Hypersensitivity/epidemiology , Masks/adverse effects , Pandemics/prevention & control , Prevalence , SARS-CoV-2 , Skin Diseases/epidemiology , Skin Diseases/etiology
4.
Dermatol Ther ; 35(10): e15753, 2022 10.
Article in English | MEDLINE | ID: covidwho-1968087

ABSTRACT

The medical face mask, widely used by health care providers (HCPs) during the COVID-19 pandemic, is reported to be associated with adverse reactions, among which acne is one of the most common. This study aims to evaluate treatment strategies employed by HCPs affected by acne in association with prolonged medical face mask use, their openness towards accessing telemedicine as a patient, and other lifestyle factors with potential influence on the evolution of their acne. Our online-based cross-sectional survey was distributed between December 17, 2020, and February 17, 2021, and targeted HCPs from different medical centers in Romania. From the n = 134 respondents, 50% reported current acne lesions and 56.7% required treatment. Of the latter, 65.8% self-medicated and 34.2% sought medical advice. The most common treatment associations between anti-acne topical products were: retinoids and salicylic acid (18.18%; n = 8), retinoids and benzoyl peroxide (13.64%; n = 6), salicylic acid and benzoyl peroxide (13.64%; n = 6), and azelaic acid together with salicylic acid (9.09%; n = 4). The health care provider responders were reluctant to use telemedicine, as only 14.2% participants were open to telemedicine. Our results suggest inadequate management of acne in HCPs using medical face masks. As with other occupational hazards and proper usage of personal protective equipment, HCPs should receive adequate screening, training, and treatment for this condition.


Subject(s)
Acne Vulgaris , COVID-19 , Dermatologic Agents , Acne Vulgaris/chemically induced , Acne Vulgaris/epidemiology , Acne Vulgaris/therapy , Anti-Bacterial Agents , Benzoyl Peroxide , COVID-19/epidemiology , Cross-Sectional Studies , Health Personnel , Humans , Pandemics , Retinoids , Salicylic Acid/therapeutic use
5.
PLoS One ; 17(5): e0268224, 2022.
Article in English | MEDLINE | ID: covidwho-1910638

ABSTRACT

BACKGROUND: Acne vulgaris is a skin disorder that affects males and females with significant impact on quality of life. The onset of the COVID-19 pandemic led to a series of non-pharmaceutical interventions globally to reduce the spread of the virus particularly since there have been no known cures or definitive treatment for the disease. One key non-pharmaceutical intervention was recommendation on wearing of face masks. There are reports of discomfort associated with wearing face mask including complaints of various skin rashes, acne and headaches which could hinder appropriate use of face masks. While the dermatological problems associated with face mask use have been comprehensively explored in high income countries, the data is sparse in sub-Saharan Africa. We aimed to determine the association between face mask use and development of acne vulgaris in our developing country setting. We subsequently determined risk factors for development of acne vulgaris such as duration of wearing face masks, type of face mask, and prior dermatological skin condition history. We aimed to also determine the potential of acne development secondary to face mask use to reducing predisposition to wearing face masks. METHODS: This was an observational cross-sectional study conducted in within two local government areas of the Federal Capital Territory, Abuja. Trained interviewers administered pre-tested questionnaires to 1316 consecutive consenting adult participants randomly approached for informed consent at various public locations. Information was inputted into MS Excel and analyzed using Epi-info. RESULTS: A total number of 1316 persons participated in this study with mean age 34.4 ±12.3 years and median age 35.5years. Male: female ratio was 1:1.41. New onset acne or worsening of acne following consistent wearing of face masks was reported by 323 (24.5%) of the 1316 participants in this study. The surgical face mask was the least likely to predispose to acne p<0.05. Compared with the surgical mask, persons using N95 face mask and cloth mask were 1.89 and 1.41 times more likely to have acne respectively. Persons with prior history of acne were more likely to develop new acne or experience worsening of acne following wearing of face mask OR 3.89, 95% CI 2.85, 5.33; p <0.05). The length of time of daily mask wearing was not significantly associated with occurrence of new onset acne or worsening of acne. Persons reporting prior histories of allergy were more likely to develop acne in this study (OR 2.01, 95% CI 1.50, 2.88; p<0.05). In this study, 192 (59.4%) of those who reported having acne following face masks use responded they have a negative predisposition to wearing masks. CONCLUSION: Our finding of greater predisposition to development or worsening of acne following consistent use of face masks could have implications for the control strategy of COVID-19. The finding that the N95 face mask was more significantly associated with acne is of concern as this is the preferred face mask in healthcare settings. It is important for the medical community to investigate feasible and safe recommendations to help alleviate this condition.


Subject(s)
Acne Vulgaris , COVID-19 , Acne Vulgaris/epidemiology , Acne Vulgaris/etiology , Adult , COVID-19/epidemiology , COVID-19/prevention & control , Cross-Sectional Studies , Female , Humans , Male , Masks/adverse effects , Middle Aged , Nigeria/epidemiology , Pandemics , Quality of Life , SARS-CoV-2 , Young Adult
6.
J Cosmet Dermatol ; 21(8): 3200-3205, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1819912

ABSTRACT

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has led to a dramatic increase in the use of personal protective equipment (PPE). However, the increased use of PPEs may lead to facial skin complaints. AIMS: This survey study aims to evaluate the effect of the COVID-19 pandemic on facial dermatoses and complaints. METHODS: A total of 1017 volunteers (age 18-60 years), consisting of healthcare workers, participated in the study. In the present study, healthcare professionals were screened for facial dermatoses and complaints between 1 and 15 April 2021 with an online survey. RESULTS: The vast majority of the survey were women (82.4%) and between 26 and 35 years old (49.2%). The most new-onset facial complaints were acne (25.3%) and lip dryness (29.2%). Along with the pandemic, 50.9% of patients with seborrheic dermatitis had an increase in lesions. Another remarkable result was a 60.5% increase in acne complaints. Moreover, the rate of exacerbations of rosacea, melasma, and lip dryness was increased after the COVID-19 pandemic (39.1%, 22.0%, and 42.7%, respectively). Exacerbations of seborrheic dermatitis, acne, and lip dryness have occurred more frequently in females when compared to males (p < 0.001). CONCLUSIONS: The current pandemic has had serious impacts on facial dermatoses which had to be managed carefully. Compared to the pre-pandemic period, there was a significant increase in the frequency and severity of complaints in facial dermatoses related to PPE. If the complaints that may develop due to PPE are known in advance, their development can be prevented by taking precautions against them.


Subject(s)
Acne Vulgaris , COVID-19 , Dermatitis, Seborrheic , Facial Dermatoses , Acne Vulgaris/epidemiology , Adolescent , Adult , COVID-19/epidemiology , Facial Dermatoses/epidemiology , Facial Dermatoses/etiology , Female , Health Personnel , Humans , Male , Middle Aged , Pandemics/prevention & control , Young Adult
7.
J Cosmet Dermatol ; 21(5): 1804-1808, 2022 May.
Article in English | MEDLINE | ID: covidwho-1714235

ABSTRACT

BACKGROUND: The COVID pandemic has affected the human race both physically and mentally. Mask use remains the standard way of preventing the spread of this virus. The continuous mask use has led to the emergence of various dermatoses like acne, pigmentation, and seborrhea in mask contact areas. The present survey has been undertaken to describe the various dermatoses encountered in the medical fraternity especially doctors, who are frequently exposed to prolonged mask use. AIMS: To estimate the frequency of various cutaneous manifestations seen among doctors following mask use via web-based online questionnaire survey. METHODS: It was a cross-sectional web-based study conducted at a tertiary care teaching institute from June 2021 to August 2021. All the doctors of the hospital completing the questionnaire were included in the study with informed consent. RESULTS: A total of 178 participants completed the survey. The most common complaint was increased sweating (55.6%) followed by acne (34.3%) and oily skin (34.3%). Significant association was found between skin changes and duration (>6 h/day) of mask use, increasing number, and type of mask (N 95) used (p value <0.05). CONCLUSION: The knowledge of various mask-induced/aggravated dermatoses will help formulate proper precautionary protocols enhancing efficient mask usage for prolonged periods.


Subject(s)
Acne Vulgaris , COVID-19 , Physicians , Skin Diseases , Acne Vulgaris/epidemiology , COVID-19/epidemiology , COVID-19/prevention & control , Cross-Sectional Studies , Hospitals, Teaching , Humans , Internet , Pandemics/prevention & control , SARS-CoV-2 , Skin Diseases/epidemiology , Skin Diseases/etiology , Tertiary Healthcare
9.
J Cosmet Dermatol ; 20(12): 3739-3746, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1467584

ABSTRACT

Background The current literature has not yet addressed mental health among acne vulgaris (AV) patients during the COVID-19 pandemic. OBJECTIVE: We aimed to investigate the psychological status of AV patients and analyze the influencing factors on psychological symptoms, during the pandemic. METHODS: This cross-sectional study included consecutively selected 220 eligible AV patients and 190 age/sex-matched healthy subjects. The Post-traumatic stress disorder (PTSD) checklist for DSM-5, Depression, Anxiety and Stress Scale-21, Brief Resilience Scale, and the Stressful Life Events List resulting from the pandemic were administered to the participants. RESULTS: There were not significantly differences between the AV patients and the control group in terms of depression, anxiety, stress, psychological resilience levels, and experienced stressful life events. Probable PTSD rate was significantly higher for AV patients (16.4%) than the control groups (9.5%) (p = 0.040). High levels of depression and anxiety, low psychological resilience, and high levels in experienced traumatic life events predicted high severity in PTSD symptoms, whereas low psychological resilience predicted high levels of depression, anxiety, and stress in AV patients. CONCLUSIONS: AV patients are at high risk of developing PTSD during the COVID-19 pandemic. The obtained results highlight the need to assess their psychological state, in particular those with low psychological resilience.


Subject(s)
Acne Vulgaris , COVID-19 , Resilience, Psychological , Acne Vulgaris/epidemiology , Cross-Sectional Studies , Humans , Mental Health , Pandemics , SARS-CoV-2
10.
J Cosmet Dermatol ; 20(12): 3730-3738, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1462845

ABSTRACT

BACKGROUND: There are a limited number of publications reporting an increase in acne in the COVID-19 outbreak. OBJECTIVE: The study aimed to evaluate the course and the clinical features of acne and possible risk factors during the COVID-19 pandemic in healthcare workers. METHOD: A total of 172 physicians (female, n = 159, male; n = 13, mean age = 35.03 ± 5.27 years) who had acne in any period of their life were included in the study. A self-administered online questionnaire was applied. RESULTS: During the COVID-19 pandemic, 45.35% of the participants reported that their acne complaints increased, 27.33% reported relapses, and 7.56% reported occurrence for the first time. Newly formed acne was reported most frequently on the chin (78.26%). The number of female participants, smoking, increased stress, and the rate of surgical mask use were found to be higher in the group whose acne occurred for the first time, relapsed, or increased than in the group whose acne complaints were unchanged or decreased (p < 0.05). In the group whose acne relapsed or increased, adult-onset acne, presence of scar, and use of systemic acne treatment before the COVID-19 pandemic were more common than in the group whose acne complaints were unchanged or decreased (p < 0.05). CONCLUSION: Almost half of the participants reported an increase in acne. More than a third of the participants reported that their acne relapsed or they had acne for the first time. In addition to the use of surgical masks, factors such as increased stress, smoking, adult-onset acne, presence of scar, and previous systemic acne treatment were found to be responsible for acne development.


Subject(s)
Acne Vulgaris , COVID-19 , Acne Vulgaris/epidemiology , Acne Vulgaris/etiology , Adult , Female , Health Personnel , Humans , Male , Pandemics , Risk Factors , SARS-CoV-2
12.
J Cosmet Dermatol ; 21(6): 2535-2541, 2022 Jun.
Article in English | MEDLINE | ID: covidwho-1376415

ABSTRACT

BACKGROUND: Mask use can lead to facial dermatoses due to factors, such as hyperhydration, seborrhea, high humidity caused by sweating, and the occlusive effect of the mask. AIM: We investigated mask-related facial dermatoses in healthcare personnel who, since the beginning of the COVID-19 pandemic, had to wear a mask for long hours. METHODS: In this study, healthcare professionals working at Medipol Mega University Hospital since the beginning of the pandemic were screened for facial dermatoses between December 2020 and February 2021 with a dermatological examination and interview. RESULTS: Of the 101 healthcare professionals, 51 (50.5%) were doctors and 50 (49.5%) nurses, and 36 (35.6%) were male and 65 (64.4%) were female. All the participants had been actively working at the hospital for 35-46 weeks since the beginning of the pandemic and wearing N95 or surgical masks for an average of 6-13 h a day. During the dermatological examination, the most common facial dermatosis was acne, which was observed in 55.4% (n = 56) of the cases. Of the 56 acne cases, 41.1% (n = 23) had acne in their history, while 58.9% (n = 33) had new-onset acne. Being female, using a N95 surgical mask compared to surgical mask, and the daily average duration of mask use were determined as risk factors for acne development due to mask use. CONCLUSIONS: The use of masks, more frequently N95, caused both an increase in existing acne and the development of new acne.


Subject(s)
Acne Vulgaris , COVID-19 , Facial Dermatoses , Acne Vulgaris/epidemiology , Acne Vulgaris/etiology , COVID-19/epidemiology , COVID-19/prevention & control , Delivery of Health Care , Facial Dermatoses/epidemiology , Facial Dermatoses/etiology , Female , Humans , Male , Pandemics , SARS-CoV-2
14.
J Cosmet Dermatol ; 20(7): 1969-1974, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1197160

ABSTRACT

BACKGROUND: Patients with acne vulgaris continue to present increasingly in dermatology outpatient clinics and seek treatment during the COVID-19 pandemic. As far as we know, the effect of isotretinoin on COVID-19 has not been studied before. AIM: We aimed to evaluate whether patients receiving oral isotretinoin are at increased risk of COVID-19 infection by comparing them with patients on topical treatment for acne vulgaris. METHODS: The data were collected retrospectively from a cohort of 267 acne vulgaris patients, who were under follow-up for acne vulgaris treatment during the pandemic period. RESULTS: Total of 227 patients (141 receiving isotretinoin treatment and 86 receiving topical treatment) were included of whom 29 patients had COVID-19 infection during acne vulgaris treatment. Fifteen (10.6%) patients were receiving oral isotretinoin and 14 (16.3%) were receiving topical acne treatment at the time of COVID-19 infection. The mean cumulative dose was 2340 ± 1988 mg at the time of COVID-19 infection. The mean elapsed time between the onset of isotretinoin treatment and positive PCR result for COVID-19 was 13.3 ± 10.3 weeks. Nine patients (64.3%) receiving isotretinoin treatment and 9 patients (60%) under topical treatment had loss of taste and smell during COVID-19 infection. Isotretinoin treatment was not found to be associated with a significant increased risk of getting COVID-19 (odds ratio, 0.671; 95% confidence interval, 0.247-1.823; P  = 0.434). CONCLUSION: As a conclusion, the results of this study encourage dermatologists and acne vulgaris patients to initiate oral isotretinoin treatment safely during the pandemic period.


Subject(s)
Acne Vulgaris , COVID-19 , Dermatologic Agents , Acne Vulgaris/drug therapy , Acne Vulgaris/epidemiology , Administration, Oral , Cohort Studies , Dermatologic Agents/adverse effects , Humans , Isotretinoin/adverse effects , Pandemics , Retrospective Studies , SARS-CoV-2 , Tertiary Care Centers
SELECTION OF CITATIONS
SEARCH DETAIL